REVIEW Temocapril HCl is a long-acting angiotensin-converting enzyme (ACE) inhibitor, used for the treatment of hypertension. It is a prodrug with a thiazepine ring, with temocaprilat being its active form. It is currently only approved for use in Japan.
REFERENCES
[1]
Jia Nan; Okamoto Hiroshi; Shimizu Toshihiro; Chiba Satoru; Matsui Yutaka; Sugawara Takeshi; Akino Masatoshi; Kitabatake Akira; A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expression Hypertension research: official journal of the Japanese Society of Hypertension (2003), 26(9), 737-42.
[2]
Yasunari K, Maeda K, Nakamura M, Watanabe T, Yoshikawa J, Asada A. Pharmacological and clinical studies with temocapril, an angiotensin converting enzyme inhibitor that is excreted in the bile. Cardiovasc Drug Rev. 2004 Fall;22(3):189-98.
Shionoiri, Hiroshi; Ochiai, Hisao; Hiroto, Seiji; ACE inhibitor, temocapril hydrochloride, excreted from bile and kidney. Cardiac Practice (1995), 6(4), 487-94.
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information.